Nan Fung Group Holdings as of March 31, 2023
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 44 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 27.9 | $41M | 226k | 181.64 | |
| Illumina (ILMN) | 18.9 | $28M | 119k | 232.55 | |
| Harmony Biosciences Hldgs In (HRMY) | 8.2 | $12M | 369k | 32.65 | |
| Seagen | 6.5 | $9.5M | 47k | 202.47 | |
| Oculis Holding Ordinary Shares (OCS) | 3.3 | $4.8M | 651k | 7.43 | |
| Exscientia Ads (EXAI) | 3.1 | $4.6M | 860k | 5.30 | |
| Somalogic Class A Com | 2.9 | $4.3M | 1.7M | 2.55 | |
| Xenon Pharmaceuticals (XENE) | 2.8 | $4.1M | 114k | 35.79 | |
| Replimune Group (REPL) | 2.3 | $3.3M | 189k | 17.66 | |
| Merus N V (MRUS) | 1.9 | $2.8M | 151k | 18.40 | |
| Iveric Bio | 1.9 | $2.7M | 112k | 24.33 | |
| Chinook Therapeutics | 1.8 | $2.6M | 114k | 23.15 | |
| Beigene Sponsored Adr (BGNE) | 1.8 | $2.6M | 12k | 215.53 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 1.7 | $2.5M | 494k | 5.16 | |
| Incyte Corporation (INCY) | 1.7 | $2.5M | 34k | 72.27 | |
| Biomea Fusion (BMEA) | 1.3 | $1.9M | 60k | 31.01 | |
| Bolt Biotherapeutics (BOLT) | 1.1 | $1.6M | 1.2M | 1.39 | |
| Pacific Biosciences of California (PACB) | 1.1 | $1.6M | 137k | 11.58 | |
| Galera Therapeutics (GRTX) | 1.1 | $1.6M | 613k | 2.56 | |
| Gitlab Class A Com (GTLB) | 0.9 | $1.3M | 37k | 34.29 | |
| Exelixis (EXEL) | 0.8 | $1.2M | 64k | 19.41 | |
| MercadoLibre (MELI) | 0.8 | $1.2M | 904.00 | 1318.06 | |
| Entrada Therapeutics (TRDA) | 0.7 | $1.1M | 74k | 14.50 | |
| Aerovate Therapeutics (AVTE) | 0.7 | $967k | 48k | 20.17 | |
| BioMarin Pharmaceutical (BMRN) | 0.5 | $702k | 7.2k | 97.24 | |
| Eargo Com New | 0.5 | $692k | 148k | 4.68 | |
| Fibrogen (FGEN) | 0.4 | $636k | 34k | 18.66 | |
| Dbv Technologies S A Sponsored Adr | 0.4 | $627k | 371k | 1.69 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $619k | 79k | 7.86 | |
| Rhythm Pharmaceuticals (RYTM) | 0.4 | $580k | 33k | 17.84 | |
| Travere Therapeutics (TVTX) | 0.4 | $576k | 26k | 22.49 | |
| ACADIA Pharmaceuticals (ACAD) | 0.4 | $564k | 30k | 18.82 | |
| Argenx Se Sponsored Adr (ARGX) | 0.4 | $533k | 1.4k | 372.58 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.3 | $447k | 4.2k | 107.22 | |
| Madrigal Pharmaceuticals (MDGL) | 0.2 | $286k | 1.2k | 242.26 | |
| Affimed Therapeutics B V | 0.2 | $278k | 373k | 0.75 | |
| Alx Oncology Hldgs (ALXO) | 0.1 | $190k | 42k | 4.52 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $149k | 18k | 8.34 | |
| Satsuma Pharmaceuticals Ord | 0.1 | $124k | 178k | 0.70 | |
| Kodiak Sciences (KOD) | 0.1 | $122k | 20k | 6.20 | |
| Nurix Therapeutics (NRIX) | 0.1 | $102k | 12k | 8.88 | |
| Abcellera Biologics (ABCL) | 0.1 | $94k | 13k | 7.54 | |
| Cerus Corporation (CERS) | 0.0 | $42k | 14k | 2.97 | |
| Invitae (NVTAQ) | 0.0 | $15k | 11k | 1.35 |
